ASX:ACW Actinogen Medical (ACW) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Actinogen Medical Stock (ASX:ACW) 30 days 90 days 365 days Advanced Chart Get Actinogen Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume275,000 shsAverage VolumeN/AMarket CapitalizationA$122.18 millionP/E RatioN/ADividend Yield8.76%Price TargetN/AConsensus RatingN/A Company Overview Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer's disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia. Read More Receive ACW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Actinogen Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ACW Stock News HeadlinesWith 100 enrolled and $13.8M in hand, Actinogen's Xanamem timeline is in full swingJune 29, 2025 | msn.comActinogen provides pivotal Alzheimer’s trial enrolment update and other business newsApril 30, 2025 | finance.yahoo.comA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.July 13 at 2:00 AM | American Alternative (Ad)Actinogen Medical Sees Change in Substantial Holder’s Voting PowerApril 22, 2025 | tipranks.comActinogen Medical Advances Alzheimer’s Research with Promising Xanamem TrialApril 1, 2025 | tipranks.comActinogen Advances Xanamem Development with FDA Meeting SuccessMarch 27, 2025 | tipranks.comActinogen Medical Advances Alzheimer’s and Depression Treatment with XanamemMarch 26, 2025 | tipranks.comActinogen Medical Advances Clinical Trials with Positive Meeting OutcomesMarch 13, 2025 | tipranks.comSee More Headlines ACW Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Actinogen Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Actinogen Medical investors own include Vocus Group (VOC), Oncolytics Biotech (ONCY), Chorus (CNU), Biosig Technologies (BSGM) and Admedus (AHZ). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryAutomobiles And Trucks Current SymbolASX:ACW CIKN/A Webwww.actinogen.com.au Phone61 2 8964 7401FaxN/AEmployees1,766Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$13.04 million Net Margins-131.34% Pretax MarginN/A Return on Equity-82.36% Return on Assets-45.37% Debt Debt-to-Equity Ratio1.62 Current Ratio13.91 Quick Ratio13.73 Sales & Book Value Annual SalesA$9.93 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.38 Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares3,080,000,000Free FloatN/AMarket CapA$122.18 million OptionableNot Optionable Beta1.74 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (ASX:ACW) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinogen Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinogen Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACW Stock Alerts